These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2893986

  • 1. Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat.
    Stone DM, Merchant KM, Hanson GR, Gibb JW.
    Neuropharmacology; 1987 Dec; 26(12):1677-83. PubMed ID: 2893986
    [Abstract] [Full Text] [Related]

  • 2. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.
    Stone DM, Stahl DC, Hanson GR, Gibb JW.
    Eur J Pharmacol; 1986 Aug 22; 128(1-2):41-8. PubMed ID: 2875893
    [Abstract] [Full Text] [Related]

  • 3. Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat.
    Johnson M, Hanson GR, Gibb JW.
    Biochem Pharmacol; 1987 Dec 01; 36(23):4085-93. PubMed ID: 2446629
    [Abstract] [Full Text] [Related]

  • 4. Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats.
    Stone DM, Hanson GR, Gibb JW.
    Neuropharmacology; 1987 Nov 01; 26(11):1657-61. PubMed ID: 2448703
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).
    Slikker W, Ali SF, Scallet AC, Frith CH, Newport GD, Bailey JR.
    Toxicol Appl Pharmacol; 1988 Jul 01; 94(3):448-57. PubMed ID: 2456631
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography.
    Battaglia G, Sharkey J, Kuhar MJ, de Souza EB.
    Synapse; 1991 Aug 01; 8(4):249-60. PubMed ID: 1681594
    [Abstract] [Full Text] [Related]

  • 9. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat.
    Johnson M, Letter AA, Merchant K, Hanson GR, Gibb JW.
    J Pharmacol Exp Ther; 1988 Mar 01; 244(3):977-82. PubMed ID: 2472482
    [Abstract] [Full Text] [Related]

  • 10. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
    Mokler DJ, Robinson SE, Rosecrans JA.
    Eur J Pharmacol; 1987 Jun 19; 138(2):265-8. PubMed ID: 2887440
    [Abstract] [Full Text] [Related]

  • 11. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.
    Battaglia G, Yeh SY, De Souza EB.
    Pharmacol Biochem Behav; 1988 Feb 19; 29(2):269-74. PubMed ID: 2452449
    [Abstract] [Full Text] [Related]

  • 12. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
    Stone DM, Johnson M, Hanson GR, Gibb JW.
    J Pharmacol Exp Ther; 1988 Oct 19; 247(1):79-87. PubMed ID: 2902215
    [Abstract] [Full Text] [Related]

  • 13. Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons.
    Schmidt CJ, Taylor VL.
    Eur J Pharmacol; 1988 Oct 26; 156(1):121-31. PubMed ID: 2463176
    [Abstract] [Full Text] [Related]

  • 14. Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats.
    Li AA, Marek GJ, Vosmer G, Seiden LS.
    Pharmacol Biochem Behav; 1989 Jul 26; 33(3):641-8. PubMed ID: 2573905
    [Abstract] [Full Text] [Related]

  • 15. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.
    O'Hearn E, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME.
    J Neurosci; 1988 Aug 26; 8(8):2788-803. PubMed ID: 2457659
    [Abstract] [Full Text] [Related]

  • 16. MDMA transiently alters biogenic amines and metabolites in mouse brain and heart.
    Steele TD, Nichols DE, Yim GK.
    Pharmacol Biochem Behav; 1989 Oct 26; 34(2):223-7. PubMed ID: 2576134
    [Abstract] [Full Text] [Related]

  • 17. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
    Ricaurte GA, Martello AL, Katz JL, Martello MB.
    J Pharmacol Exp Ther; 1992 May 26; 261(2):616-22. PubMed ID: 1374470
    [Abstract] [Full Text] [Related]

  • 18. In vitro reactivation of rat cortical tryptophan hydroxylase following in vivo inactivation by methylenedioxymethamphetamine.
    Stone DM, Hanson GR, Gibb JW.
    J Neurochem; 1989 Aug 26; 53(2):572-81. PubMed ID: 2568404
    [Abstract] [Full Text] [Related]

  • 19. Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity.
    Johnson M, Stone DM, Bush LG, Hanson GR, Gibb JW.
    Eur J Pharmacol; 1989 Feb 28; 161(2-3):181-8. PubMed ID: 2470597
    [Abstract] [Full Text] [Related]

  • 20. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB.
    J Pharmacol Exp Ther; 1987 Sep 28; 242(3):911-6. PubMed ID: 2443644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.